Disability improvements over 12 months with lasmiditan for acute treatment of migraine: Interim analysis of migraine disability assessment (MIDAS) scale changes in the gladiator study

Authors
Category Primary study
ConferenceCephalalgia
Year 2018
This article has no abstract
Epistemonikos ID: 457d67b3d415846cd3e3dfa6e8333adf6340e45c
First added on: Apr 29, 2026